Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells

Cancer Detection and Prevention

Volumn 24, Issue 5, 2000, Pages 452-458

  Bowen, D ^a   Southerland, W M ^a   Johnson, D H ^a   Hawkins M , Jr ^a   Hughes, D E ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

5 fluorouracil; Bone marrow; High dose methotrexate; Human breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; FOLIC ACID ANTAGONIST; METHOTREXATE; TRIMETREXATE;

ARTICLE; BONE MARROW CELL; BREAST TUMOR; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; HUMAN;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; BREAST NEOPLASMS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FLUOROURACIL; FOLIC ACID ANTAGONISTS; HUMANS; METHOTREXATE; TRIMETREXATE; TUMOR CELLS, CULTURED;

EID: 0033671156     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Meta-analysis of randomized testing the biochemical modulation of fluorouracil by methotrexate in metastatic cancer
2. Does biomodulation of 5-fluorouracil improve results?
3. 5-Fluorouracil modulates the toxicity of high dose methotrexate
4. A phase I study of methotrexate administration following 5-fluorouracil
5. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate
6. Modulation of highdose methotrexate toxicity by a nontoxic level of 5-fluorouracil
7. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced recurrent squamous cell head and neck cancer
8. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells
9. 5-Fluorouracil maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow
10. Biochemical pharmacology of the lipophilic antifolate trimetrexate
11. 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor. I. Effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo
12. Polyglutamation of methotrexate. Is methotrexate a prodrug?
13. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates
14. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells
15. 14C-formate incorporation into RNA and protein
16. 14C-formate into nucleic acids and protein
17. Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroylpolyglutamate substrates and with dihydropteroyl polyglutamate inhibitors
18. Polyglutamation, an important element in methotrexate cytotoxiity and selectivity in tumor versus murine granulocyte progenitor cells in vitro
19. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow